Amphastar Pharma (AMPH.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov24

Amphastar Pharmaceuticals to Participate in Piper Sandler Healthcare Conference Analyst Fireside Chat

11:00

Nov11

AVI Reports Q3 2025 Earnings

00:17

Nov7

Amphastar Pharma released FY2025 9 Months Earnings on November 6 After-Market EST, with actual revenue of USD 536.78 M and EPS of USD 1.52

00:00

Amphastar Pharma released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 191.84 M (forecast USD 185.07 M), actual EPS USD 0.37 (forecast USD 0.731)

00:00

Oct30

Amphastar Pharma to Release FY2025 Q3 Earnings on November 6 After-Market EST, Forecast Revenue USD 185.07 M, EPS USD 0.731

00:50

Aug12

Amphastar Pharmaceuticals Signs Exclusive Licensing Agreement with Nanjing Anji

10:01

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 191.84 M, Net Income 17.35 M, EPS 0.37

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 174.41 M, Net Income 31.03 M, EPS 0.64

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 170.53 M, Net Income 25.29 M, EPS 0.51

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More